GlassScriptPhysician profile
Susan Flores
NPI 1225005457
$1,964.15
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $535 · 2022: $22.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $336.03 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $292.29 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.27 | 2019-2020 | |
| Pfizer INC. | $182.48 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $130.67 | 2019-2020 | |
| Novo Nordisk INC | $97.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $96.29 | 2019-2020 | |
| Lilly USA, LLC | $95.09 | 2019-2020 | |
| Allergan, INC. | $94.43 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.12 | 2019 | |
| Glaxosmithkline, LLC. | $63.57 | 2019-2020 | |
| Abbvie INC. | $62.67 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $52.70 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $39.02 | 2019 | |
| Merck Sharp & Dohme LLC | $38.43 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.23 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.62 | 2019 | |
| Melinta Therapeutics, LLC | $18.31 | 2019 | |
| Astellas Pharma US INC | $18.00 | 2019 | |
| Amarin Pharma, INC. | $12.56 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.